126 related articles for article (PubMed ID: 7649582)
1. Amylin stimulates plasma renin concentration in humans.
Cooper ME; McNally PG; Phillips PA; Johnston CI
Hypertension; 1995 Sep; 26(3):460-4. PubMed ID: 7649582
[TBL] [Abstract][Full Text] [Related]
2. Rat amylin mediates a pressor response in the anaesthetised rat: implications for the association between hypertension and diabetes mellitus.
Haynes JM; Hodgson WC; Cooper ME
Diabetologia; 1997 Mar; 40(3):256-61. PubMed ID: 9084962
[TBL] [Abstract][Full Text] [Related]
3. Circulating amylin in human essential hypertension: heritability and early increase in individuals at genetic risk.
Kailasam MT; Parmer RJ; Tyrell EA; Henry RR; O'Connor DT
J Hypertens; 2000 Nov; 18(11):1611-20. PubMed ID: 11081774
[TBL] [Abstract][Full Text] [Related]
4. Dose response characteristics for the hyperglycemic, hyperlactemic, hypotensive and hypocalcemic actions of amylin and calcitonin gene-related peptide-I (CGRP alpha) in the fasted, anaesthetized rat.
Young AA; Rink TJ; Wang MW
Life Sci; 1993; 52(21):1717-26. PubMed ID: 8502117
[TBL] [Abstract][Full Text] [Related]
5. Amylin and amylin-amide lack an acute effect on blood glucose and insulin.
Ghatei MA; Datta HK; Zaidi M; Bretherton-Watt D; Wimalawansa SJ; MacIntyre I; Bloom SR
J Endocrinol; 1990 Feb; 124(2):R9-11. PubMed ID: 2179452
[TBL] [Abstract][Full Text] [Related]
6. Amylin binding in rat renal cortex, stimulation of adenylyl cyclase, and activation of plasma renin.
Wookey PJ; Tikellis C; Du HC; Qin HF; Sexton PM; Cooper ME
Am J Physiol; 1996 Feb; 270(2 Pt 2):F289-94. PubMed ID: 8779889
[TBL] [Abstract][Full Text] [Related]
7. Amylin-induced in vivo insulin resistance in conscious rats: the liver is more sensitive to amylin than peripheral tissues.
Koopmans SJ; van Mansfeld AD; Jansz HS; Krans HM; Radder JK; Frölich M; de Boer SF; Kreutter DK; Andrews GC; Maassen JA
Diabetologia; 1991 Apr; 34(4):218-24. PubMed ID: 2065857
[TBL] [Abstract][Full Text] [Related]
8. Interaction of the renal amylin and renin-angiotensin systems in animal models of diabetes and hypertension.
Wookey PJ; Cao Z; Cooper ME
Miner Electrolyte Metab; 1998; 24(6):389-99. PubMed ID: 9930378
[TBL] [Abstract][Full Text] [Related]
9. Direct plasma radioimmunoassay for rat amylin-(1-37): concentrations with acquired and genetic obesity.
Pieber TR; Roitelman J; Lee Y; Luskey KL; Stein DT
Am J Physiol; 1994 Jul; 267(1 Pt 1):E156-64. PubMed ID: 8048505
[TBL] [Abstract][Full Text] [Related]
10. The effect of islet amyloid polypeptide (amylin) and calcitonin gene-related peptide on glucose removal in the anaesthetized rat and on insulin secretion from rat pancreatic islets in vitro.
Tedstone AE; Nezzer T; Hughes SJ; Clark A; Matthews DR
Biosci Rep; 1990 Aug; 10(4):339-45. PubMed ID: 2249001
[TBL] [Abstract][Full Text] [Related]
11. Amylin, calcitonin gene-related peptide, and adrenomedullin: effects on thiazide receptor and calcium.
Blakely P; Vaughn DA; Fanestil DD
Am J Physiol; 1997 Mar; 272(3 Pt 2):F410-5. PubMed ID: 9087686
[TBL] [Abstract][Full Text] [Related]
12. Glucoregulatory endocrine responses to intermittent exercise of different intensities: plasma changes in a pancreatic beta-cell peptide, amylin.
Kraemer RR; Acevedo EO; Synovitz LB; Durand RJ; Johnson LG; Petrella E; Fineman MS; Gimpel T; Castracane VD
Metabolism; 2002 May; 51(5):657-63. PubMed ID: 11979402
[TBL] [Abstract][Full Text] [Related]
13. Evidence that amylin stimulates lipolysis in vivo: a possible mediator of induced insulin resistance.
Ye JM; Lim-Fraser M; Cooney GJ; Cooper GJ; Iglesias MA; Watson DG; Choong B; Kraegen EW
Am J Physiol Endocrinol Metab; 2001 Apr; 280(4):E562-9. PubMed ID: 11254462
[TBL] [Abstract][Full Text] [Related]
14. Effects of rat amylin on renal function in the rat.
Vine W; Smith P; LaChappell R; Blase E; Young A
Horm Metab Res; 1998 Aug; 30(8):518-22. PubMed ID: 9761383
[TBL] [Abstract][Full Text] [Related]
15. Rat amylin-(8-37) enhances insulin action and alters lipid metabolism in normal and insulin-resistant rats.
Hettiarachchi M; Chalkley S; Furler SM; Choong YS; Heller M; Cooper GJ; Kraegen EW
Am J Physiol; 1997 Nov; 273(5):E859-67. PubMed ID: 9374670
[TBL] [Abstract][Full Text] [Related]
16. Amylin, amyloid and age-related disease.
Cooper GJ; Tse CA
Drugs Aging; 1996 Sep; 9(3):202-12. PubMed ID: 8877314
[TBL] [Abstract][Full Text] [Related]
17. In vivo insulin resistance induced by amylin primarily through inhibition of insulin-stimulated glycogen synthesis in skeletal muscle.
Frontoni S; Choi SB; Banduch D; Rossetti L
Diabetes; 1991 May; 40(5):568-73. PubMed ID: 2022302
[TBL] [Abstract][Full Text] [Related]
18. Amylin and CGRP induce insulin resistance via a receptor distinct from cAMP-coupled CGRP receptor.
Kreutter DK; Orena SJ; Torchia AJ; Contillo LG; Andrews GC; Stevenson RW
Am J Physiol; 1993 Apr; 264(4 Pt 1):E606-13. PubMed ID: 8386456
[TBL] [Abstract][Full Text] [Related]
19. Reversal of the inhibitory effects of calcitonin gene-related peptide (CGRP) and amylin on insulin secretion by the 8-37 fragment of human CGRP.
Silvestre RA; Salas M; Dégano P; Peiró E; Marco J
Biochem Pharmacol; 1993 Jun; 45(11):2343-7. PubMed ID: 8517876
[TBL] [Abstract][Full Text] [Related]
20. Anti-insulin effects of amylin and calcitonin-gene-related peptide on hepatic glycogen metabolism.
Gómez-Foix AM; Rodriguez-Gil JE; Guinovart JJ
Biochem J; 1991 Jun; 276 ( Pt 3)(Pt 3):607-10. PubMed ID: 1905922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
